Pathophysiology of fluid retention in heart failure

Contributions to Nephrology

Volumn 164, Issue , 2010, Pages 46-53

  Chaney, Erin ^a   Shaw, Andrew ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART FAILURE; HUMAN; KIDNEY FAILURE; METABOLIC DISORDER; METABOLISM; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HEART FAILURE; HUMANS; NEUROSECRETORY SYSTEMS; RENAL INSUFFICIENCY; WATER-ELECTROLYTE IMBALANCE;

EID: 77955482218     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000313720     Document Type: Article

References (30)

1. Drexler H, Hasenfuss G: Physiology of the normal and failing heart; in Crawford MH, Dimarco JP, Paulus WJ (eds): Cardiology, ed 2. Edinburgh, Mosby, 2004, pp 829-844.
2. Rea ME, Dulap ME: Renal hemodynamics in heart failure: implications for treatment. Curr Opin Nephrol Hypertens 2008;17:87-92.
3. Briggs J P, Kriz W, Schnermann JB: Overview of kidney function and structure; in Greenberg A, Cheung AK, Falk RJ, Coffman TM, Jenette JC (eds): Primer on Kidney Diseases, ed 4. Philadelphia, Elsevier Saunders, 2001, pp 2-19.
4. Shotan A, Dacca S, Shochat M, Kazatsher M, Blondheim DS, Simcha M: Fluid overload contributing to heart failure. Nephrol Dial Transplant 2005;20(suppl 7):24-27.
5. Iwatsuki S, Popovtzer MM, Corman JL, Ishikawa M, Putnam C W, Katz FH, Starzi TE: Recovery from 'hepatorenal syndrome' after orthotopic liver transplantation. N Engl J Med 1973;29:1155-1159.
6. Singer DR, Markandu ND, Buckley MG, Miller MA, Sagnella GA, Lachno DR, Cappuccio FP, Murday A, Yacoub MH, MacGregor GA: Blood pressure and endocrine response to changes in dietary sodium intake in cardiac transplant recipients. Implications for the control of sodium balance. Circulation 1994;89:1153-1159.
7. Schrier RW: Pathogenesis of sodium and water retention in high-output and lowoutput cardiac failure, nephritic syndrome, cirrhosis, and pregnancy (1). N Engl J Med 1988;319:1065-1072.
8. Schrier RW: Pathogenesis of sodium and water retention in high-output and lowoutput cardiac failure, nephritic syndrome, cirrhosis, and pregnancy (2). N Engl J Med 1988;319:1127-1134.
9. Schrier RW: Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 2006;119: S47-S53.
10. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J: The sympathetic nervous system in heart failure. J Am Coll Cardiol 2009;54:1747-1762.
11. Cohn HN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.
12. Mann DL, Kent RL, Parsons B, Cooper G 4th: Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804.
13. Ellison GM, Torella D, Karakikes I, Purushothaman S, Curcio A, Gasparri C, Indolfi C, Cable NT, Goldspink DF, Nadal-Ginard B: Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem 2007;282:11397-11409.
14. Bell-Reuss E, Trevino DL, Gottschalk CW: Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 1976;57:1104-1107.
15. Francis GS: The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J 1989;118:642-648.
16. Sadoshima J, Izumo S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993;73:413-423.
17. Farquharson CA, Struthers AD: Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 2000;101:594-597.
18. August JT, Nelson DH, Thorn GW: Response of normal subjects to large amounts of aldosterone. J Clin Invest 1958;37:1549-1555.
19. Rovner DR, Conn JW, Knopf RF, Cohen EL, Hsuch MT-Y: Nature of renal escape from the sodium-retaining effect of aldosterone in primary aldosteronism and in normal subjects. J Clin Endocrinol Metab 1965;25:53-64.
20. Chatterjee K: Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol 2005;95:8B-13B.
21. Szatalowicz VL, Arnold PE, Chaimovitz C, Bichet D, Berl T, Schrier RW: Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med 1981;305:263-266.
22. Goldsmith SR, Francis GS, Cowley AW, Levine TB, Cohn JN: Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol 1983;1:1385-1390.
23. Packer M, Lee WH, Kessler PD: Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation 1987;75(suppl 4):80-92.
24. Ishikawa S, Schrier RW: Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clin Endocrinol 2003;58:1-17.
25. Martin PY, Abraham WT, Lieming X, Olson BR, Oren RM, Ohara M, Schrier RW: Selective v2-receptor vasopressin antagonisms decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J Am Soc Nephrol 1999;10:2165-2170.
26. Pacher R, Stanek B, Hulsmann M, Koller-Strametz J, Berger R, Schuller M, Hartter E, Ogris E, Frey B, Heinz G, Maurer G: Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996;27:633-641.
27. Kang YM, He RL, Yang LM, Qin DN, Guggilam A, Elks C, Yan N, Guo Z, Francis J: Brain tumor necrosis factor modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc Res 2009;83:737-746.
28. Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A: Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther 2004;102:223-241.
29. Raine A, Erne P, Burgisser E, Muller FB, Bolli P, Burkhart F, Buhler FR: Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986;315:533-537.
30. Showalter CJ, Zimmerman RS, Schwab TR, Edwards BS, Opgenorth TJ, Burnett JC Jr: Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol 1988;254: R453-R456.